Myelofibrosis natural history, complications and prognosis: Difference between revisions
Varun Kumar (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{Myelofibrosis}} | {{Myelofibrosis}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Natural History, Complications and Prognosis== | |||
==Prognosis== | ===Prognosis=== | ||
Myelofibrosis leads to progressive bone marrow failure. The mean survival is five years and causes of death include infection, bleeding, organ failure, portal hypertension, and leukemic transformation. | Myelofibrosis leads to progressive bone marrow failure. The mean survival is five years and causes of death include infection, bleeding, organ failure, portal hypertension, and leukemic transformation. | ||
| Line 13: | Line 16: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Needs content]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Revision as of 20:16, 17 September 2012
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis natural history, complications and prognosis |
|
FDA on Myelofibrosis natural history, complications and prognosis |
|
CDC on Myelofibrosis natural history, complications and prognosis |
|
Myelofibrosis natural history, complications and prognosis in the news |
|
Blogs on Myelofibrosis natural history, complications and prognosis |
|
Risk calculators and risk factors for Myelofibrosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Natural History, Complications and Prognosis
Prognosis
Myelofibrosis leads to progressive bone marrow failure. The mean survival is five years and causes of death include infection, bleeding, organ failure, portal hypertension, and leukemic transformation.